Prevalence of the metabolic syndrome and overweight among adults in China
Prevalence of the metabolic syndrome and overweight among adults in China
复制标题
DOI：
10.1016/s0140-6736(05)66375-1
复制
发表时间：
2005-04-16
期刊：
影响因子：
168.9
通讯作者：
He, J
中科院分区：
文献类型：
--
作者：
Gu, DF;Reynolds, K;He, J
背景代谢综合征和肥胖是心血管疾病的主要危险因素。关于中国代谢综合征患病率的信息很少。我们的目的是提供最新的估计代谢综合征和超重的患病率在一般成年populationinChina.Methods我们做了一个横断面调查，在全国代表性的样本15 540名中国成年人，年龄在35-74岁，在2000-01。根据美国国家胆固醇教育计划的指南定义代谢综合征。超重定义为体重指数≥ 25.0 kg/m2。结果代谢综合征的年龄标准化患病率男性为9.8%（95%CI 9.0-10.6），女性为17.8%（16.6-19.0）。男性的年龄标准化超重患病率为26.9%（25.7-28.1），女性为31.1%（29.7-32.5）。代谢综合征和超重的患病率北方高于南方，城市高于农村。解释我们的结果表明，很大一部分中国成年人患有代谢综合征，超重已成为中国重要的公共卫生问题。这些发现强调了迫切需要制定预防、检测和治疗超重和代谢综合征的国家战略，以减轻中国心血管疾病的社会负担。
Background The metabolic syndrome and obesity are major risk factors for cardiovascular disease. Little information exists on the prevalence of the metabolic syndrome in China. We aimed to provide up-to-date estimates of the prevalence of the metabolic syndrome and overweight in the general adult population in China.Methods We did a cross-sectional survey in a nationally representative sample of 15 540 Chinese adults aged 35-74 years in 2000-01. Metabolic syndrome was defined according to guidelines from the US National Cholesterol Education Program. Overweight was defined as body-mass index of 25.0 kg/m(2) or greater.Findings The age-standardised prevalence of metabolic syndrome was 9.8% (95% CI 9.0-10.6) in men and 17.8% (16.6-19.0) in women. The age-standardised prevalence of overweight was 26.9% (25.7-28.1) in men and 31.1% (29.7-32.5) in women. The prevalence of the metabolic syndrome and overweight was higher in northern than in southern China, and higher in urban than rural residents.Interpretation Our results indicate that a large proportion of Chinese adults have the metabolic syndrome and that overweight has become an important public health problem in China. These findings emphasise the urgent need to develop national strategies for the prevention, detection, and treatment of overweight and the metabolic syndrome, to reduce the societal burden of cardiovascular disease in China.